Connor, Clark & Lunn Investment Management (CC&L)
ALNY icon

Connor, Clark & Lunn Investment Management (CC&L)’s Alnylam Pharmaceuticals ALNY Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$200K Buy
+666
New +$201K ﹤0.01% 1566
2024
Q4 		– Sell
-73,320
Closed -$20.2M – 1397
2024
Q3 		$20.2M Buy
73,320
+13,422
+22% +$3.49M 0.1% 169
2024
Q2 		$14.6M Buy
59,898
+44,455
+288% +$7.02M 0.06% 228
2024
Q1 		$2.31M Buy
+15,443
New +$2.58M 0.01% 631
2023
Q2 		– Sell
-12,901
Closed -$2.58M – 1298
2023
Q1 		$2.58M Buy
12,901
+11,661
+940% +$2.45M 0.01% 502
2022
Q4 		$295K Buy
+1,240
New +$264K ﹤0.01% 981
2021
Q3 		– Sell
-8,964
Closed -$1.52M – 1023
2021
Q2 		$1.52M Sell
8,964
-6,092
-40% -$892K 0.01% 600
2021
Q1 		$2.13M Buy
15,056
+4,683
+45% +$705K 0.01% 550
2020
Q4 		$1.35M Buy
+10,373
New +$1.39M 0.01% 584
2020
Q1 		– Sell
-1,850
Closed -$213K – 1003
2019
Q4 		$213K Buy
+1,850
New +$184K ﹤0.01% 827
2015
Q1 		– Sell
-5,100
Closed -$495K – 563
2014
Q4 		$495K Buy
+5,100
New +$473K ﹤0.01% 393
2014
Q1 		– Sell
-15,200
Closed -$1.04M – 673
2013
Q4 		$1.04M Buy
+15,200
New +$907K 0.01% 362

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s ALNY Position: Q2 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) opened a new position in Alnylam Pharmaceuticals (ALNY) in Q2 2026: 666 shares worth $200K. The stake represents ﹤0.01% of the portfolio and ranks #1566 among its holdings. This is a return to the name: Connor, Clark & Lunn Investment Management (CC&L) previously reported a position in ALNY as recently as Q3 2024.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ALNY in Q4 2013 and has held it in 12 quarters since. The position peaked at $20.2M in Q3 2024. 793 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) held 666 shares of Alnylam Pharmaceuticals worth $200K as of Q2 2026.
  • Alnylam Pharmaceuticals was a new Connor, Clark & Lunn Investment Management (CC&L) position in Q2 2026.
  • Alnylam Pharmaceuticals made up ﹤0.01% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q2 2026, its #1566 holding.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Alnylam Pharmaceuticals in Q4 2013 and has held it in 12 quarters since.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Alnylam Pharmaceuticals position peaked at $20.2M in Q3 2024.
  • 793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.